Indoco Remedies Promoter Suresh G Kare Acquires Additional Shares via Open Market
Indoco Remedies Ltd 路 Acquisition/ Disposal of Shares 路 07 Nov 2026, 4:37 pm
Indoco Remedies Promoter Suresh G Kare Acquires Additional Shares via Open Market Promoter Suresh G Kare acquired 1,335 equity shares (0.001% stake) of Indoco Remedies Limited through an open market transaction on 6th Nov'26. Following this acquisition, his holding in the company increased from 13,12,045 shares (1.421%) to 13,13,380 shares (1.423%). Indoco Remedies' total paid-up equity and diluted voting capital remained unchanged at Rs. 18.46 crore, consisting of 9,23,18,455 equity shares of face value Rs. 2 each.
Original exchange filing (PDF)
More announcements from Indoco Remedies Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare & Aruna Kare 路 18 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others 路 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare 路 09 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ms. Aditi M Panandikar & Ms. Madhura Suresh Kare 路 04 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others 路 03 Nov 2026
- Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-09-2026 路 29 Oct 2026
- Audio recording of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026 路 27 Oct 2026
